The 2017 U.S. Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure (HTN Guideline) in adults, sponsored by the American College of Cardiology, the American Heart Association, and a number of other professional societies, has recommended radical changes in the way high blood pressure (BP) is diagnosed and treated. This online module provides the updated recommendations from these guidelines.
RH is defined as blood pressure (BP) that is elevated above goal despite the use of 3 or more medications, commonly a long-acting calcium channel blocker, a renin-angiotensin system blocker (angiotensin-converting enzyme inhibitor or angiotensin receptor blocker) and a diuretic. All of the previously mentioned medications have to be taken in maximum or maximally tolerated doses and at the proper dosing frequency. Many patients with RH have a secondary cause for the HTN. This module identifies patients with resistant hypertension according to the definition in the AHA 2018 Statement on Resistant Hypertension.
- Teacher: Reviewer Test